Retatrutide and Resting Metabolic Rate: Glucagon Advantage

The biggest unsolved problem in weight loss is not losing weight -- it is keeping it off. Metabolic adaptation, the process by which your body reduces its calorie burn in response to weight loss, makes long-term maintenance extraordinarily difficult. Your resting metabolic rate (RMR) -- the calories you burn simply existing -- can drop by 10-15% beyond what weight loss alone would predict. This means a person who has lost weight burns fewer calories than a person who has always been that weight.

Retatrutide introduces a potential solution. Its glucagon receptor activation increases energy expenditure through thermogenesis, essentially telling your body to burn more fuel even as it gets smaller. This is the "glucagon advantage" -- and it may be the reason retatrutide produces 24% weight loss (Jastreboff et al., NEJM 2023) rather than the 15-17% seen with GLP-1-only medications that rely entirely on appetite suppression.

Understanding Metabolic Adaptation

Metabolic adaptation is your body's survival mechanism. When energy intake drops, the body reduces energy expenditure to preserve fuel reserves. This manifests in several ways: reduced thyroid hormone output, decreased sympathetic nervous system activity, improved mitochondrial efficiency (doing more work with less fuel), and reduced non-exercise activity thermogenesis (NEAT) -- you unconsciously move less, fidget less, and conserve energy.

On GLP-1-only medications like semaglutide, weight loss comes almost entirely from reduced appetite. The body responds by reducing metabolic rate to match the lower caloric intake, eventually creating a new equilibrium where weight loss stalls. This is the dreaded "plateau" that virtually every patient encounters.

How Glucagon Fights Metabolic Adaptation

Glucagon receptor activation introduces a fundamentally different approach to weight loss -- one that does not rely solely on eating less but also on burning more. The thermogenic effects of glucagon operate through several mechanisms:

The Dual-Mechanism Weight Loss Model

Retatrutide's weight loss appears to come from two complementary mechanisms, unlike previous medications that relied primarily on one:

The additional 3-7% weight loss that retatrutide produces beyond tirzepatide likely comes primarily from the glucagon-driven increase in energy expenditure, not from additional appetite suppression. Patients on retatrutide may not eat dramatically less than those on tirzepatide, but they burn more at rest.

Strategies to Protect Your Resting Metabolic Rate

While glucagon provides a built-in metabolic advantage, you can further support your RMR during retatrutide treatment:

• Resistance training: Preserving muscle mass directly protects RMR. Each pound of muscle burns 6-7 calories per day at rest. Maintaining 10 extra pounds of muscle over the course of weight loss protects 60-70 daily calories of metabolic expenditure.
• Adequate protein: Protein has a higher thermic effect than carbohydrates or fat -- your body burns more calories digesting and processing protein. This contributes to slightly higher energy expenditure.
• Avoid extreme caloric restriction: Eating below 1,000 calories daily accelerates metabolic adaptation. Let retatrutide control the deficit naturally through appetite suppression rather than deliberately starving yourself further.
• Stay active: Maintain daily movement through walking, household activities, and general physical engagement. NEAT decline is a major contributor to metabolic adaptation.
• Adequate sleep: Poor sleep disrupts thyroid function and growth hormone release, both of which influence metabolic rate.

To explore currently available weight loss treatment options, visit our treatments page.